NDC 0169-5306-10
RIVFLOZA 160 mg/mL
nedosiran · INJECTION, SOLUTION
Nedosiran (Rivfloza) is a prescription injection given under the skin to treat primary hyperoxaluria type 1, a rare genetic disorder that causes kidney damage from excess oxalate buildup. It works by reducing oxalate production in the body.
Key Facts
- Brand Name
- RIVFLOZA
- Generic Name
- nedosiran
- NDC Code (Package)
0169-5306-10- NDC Code (Product)
0169-5306- Manufacturer
- Novo Nordisk
- Strength
- 160 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA215842
- Marketing Start
- 02/19/2024
Recall History
No Recall HistoryView Full Drug Page
RIVFLOZA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.